Skip to main content
. 2020 Sep;73(3):523–532. doi: 10.1016/j.jhep.2020.04.008

Fig. 4.

Fig. 4

Country-level estimates of anti-HDV prevalence among HBsAg-positive people.

(A) General populations; (B) Hepatology clinic populations. Colour indicates HDV seroprevalence.